BTIG Reiterates Buy Rating on SBC Medical Group (SBC)
Tweet Send to a Friend
BTIG analyst Sam Eiber reiterated a Buy rating and $8.00 price target on SBC Medical Group (NASDAQ: SBC).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


